U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Short descriptor: Cov-19 amp prb hgh thruput
Look up U0003 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
U0003 is the HCPCS Level II code for Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (2026). It belongs to Section U — Coronavirus Laboratory Tests. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Priced by carriers (clinical lab).
Classification & CMS Attributes
- Section
- U: Coronavirus Laboratory Tests
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Priced by carriers (clinical lab) (indicator 22)
- Type of Service
- Diagnostic laboratory
- Effective Date
- 2023-05-12
- Termination Date
- 2023-05-11
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference U0003 with the canonical source and edition:
U0003 — Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/U0003
Canonical URL: https://icd10codingpro.com/hcpcs-codes/U0003